TYK Medicines Inc., a joint stock company incorporated in the People's Republic of China, has announced a private placement involving the issuance of 9,230,000 new H shares under a general mandate. The company has entered into a Placing Agreement with a Placing Agent, who will act on a best effort basis to procure Placees to purchase the shares at a price of HK$17.01 per share. This issuance represents approximately 2.52% of the company's total issued shares. The expected closing date for the placement is August 5, 2025, subject to conditions being met. Shareholders and potential investors are advised to exercise caution when dealing with the company's shares.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. TYK Medicines Inc. published the original content used to generate this news brief on July 29, 2025, and is solely responsible for the information contained therein.